Introducing insitro's TherMLTM: Rapidly engineering the right therapeutic for the right target

Summary

Share The primary driver of clinical attrition in drug discovery is often not insufficient scientific rigor, it is misalignment between the biological target and the therapeutic intervention. Discovery organizations have historically structured themselves around technological capabilities, operating as either small molecule, biologics, or oligonucleotide specialists. This specialization creates an underappreciated constraint: modality selection becomes influenced by internal capabilities rather than the requirements of disease biology. The tool shapes the task, when the task should shape the tool. TherML™ (Therapeutics Machine Learning) is insitro’s integrated design engine, built to reverse this logic. Spanning small molecules, oligonucleotides, and complex biologics within a single platform, TherML transitions drug discovery from stochastic screening to predictive and adaptive engineering, simultaneously optimizing for both potency and developability in silico before committing substantial resources. TherML is the therapeutic design layer of insitro’s end-to-end discovery platform, rapidly translating biological insight into optimally designed interventions. Our discovery engine draws on genetic and phenotypic data from the world’s largest biobanks, complex imaging, and large-scale genetic perturbations to map how specific changes drive cellular phenotypes. These converge in the Virtual Human™, a unified computational representation of causal biology that allows us to understand not merely that a gene associates with disease, but how its perturbation propagates through biological systems to produce pathology. Where the Virtual Human addresses what mechanism to target, TherML addresses how best to intervene. At the heart of TherML is a closed-loop active learning system of iterative data generation via differentiated experimental capabilities and AI-driven design cycles. Computational predictions guide experimental design, selecting experiments that maximize information gain. Subsequent experimental results refine the models—each cycle sharpens the next. The platform integrates directly with insitro’s automated laboratories, enabling continuous improvement in predictive performance that compounds over time. In addition, rather than optimizing one trait at a time—potency, permeability, toxicity, etc. —TherML enables integrated optimization across two critic…